Gilead Sciences, Inc. (GILD)
62.75 0.00 (0.00%)
After hours: 4:32PM EST
Chart Events
Performance Outlook
| Previous Close | 63.01 |
| Open | 62.79 |
| Bid | 62.68 x 800 |
| Ask | 62.76 x 800 |
| Day's Range | 62.18 - 63.32 |
| 52 Week Range | 56.56 - 85.97 |
| Volume | 6,801,383 |
| Avg. Volume | 8,975,643 |
| Market Cap | 78.851B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | 640.31 |
| EPS (TTM) | 0.10 |
| Earnings Date | Apr 28, 2021 - May 03, 2021 |
| Forward Dividend & Yield | 2.84 (4.51%) |
| Ex-Dividend Date | Mar 12, 2021 |
| 1y Target Est | 74.54 |
Fair Value
Related Research
- Editor's PickYahoo Finance Video
Doctor: Health care workers are ‘frustrated and concerned’ over lifting of virus mandates
Dr. Heather Yeo, SurvivorNet Medical Advisor & Associate Professor of Surgery and Associate Professor of Population Health Sciences at New York Presbyterian Weill Cornell Medicine, joins Yahoo Finance’s Kristin Myers to discuss the latest coronavirus updates.
- Barrons.com
Gilead’s Covid-19 Antiviral Has Been a Major Earner. An Analyst Says It Should Test Its Cat Remdesivir Next.
Sales of Gilead’s Covid-19 antiviral remdesivir could reach $3 billion this year. An analyst says the company should try the cat version of the drug on humans to make revenues from Covid-19 antivirals last.
- Business Wire
Diodes Incorporated to Participate at the Loop Capital Markets Conference on March 11
Diodes Incorporated (Nasdaq: DIOD), today announced Brett Whitmire, Chief Financial Officer; Emily Yang, Sr. Vice President of Worldwide Sales and Marketing; and Laura Mehrl, Director of Investor Relations, will participate in the Loop Capital Markets Virtual Consumer, Industrials & TMT Conference on Thursday, March 11, 2021. Management will be available throughout the day to host conference calls with investors participating in the event.
